key: cord-1005316-lieno0tp
authors: Musbahi, Aya; Mahawar, Kamal
title: Comment on: Impact of the COVID-19 pandemic on bariatric surgery in North America – A retrospective analysis of 834,647 patients
date: 2022-04-22
journal: Surg Obes Relat Dis
DOI: 10.1016/j.soard.2022.04.008
sha: 5717bd20efb9ead7a263b2b67064ca720b60bd72
doc_id: 1005316
cord_uid: lieno0tp

nan

It is however interesting that the patients who underwent BMS during the pandemic were younger and had fewer co-morbidities. This suggests that less risky patients were prioritized for surgery during the pandemic contrary to the authoritarian advice published at the time (4). Rubino and colleagues had recommended that patients at the highest risk of death from COVID-19 should be prioritized during the pandemic. However, this study (1) and the findings of the GENEVA study (5) which reported on 30-day morbidity and mortality of BS worldwide during the pandemic suggest that this advice was largely ignored and surgical teams prioritized less risky patients. This may be because the frequency and outcome of perioperative COVID-19 were unknown in this group of patients when the BMS resumed. This was one of the main reasons why we conducted the GENEVA study. Interestingly, only 43 (0.56%) patients developed symptomatic postoperative COVID-19 in the GENEVA cohort and only one patient (out of 7734) died due to postoperative COVID-19. It would have been interesting to know how many patients developed symptomatic COVID-19 (and mortality as a consequence of that) after BMS during the pandemic in North America, but this study (1) does not report these numbers.

A slight increase in the proportion of Sleeve Gastrectomy (SG) during the pandemic in this study (1) might suggest a preference for a less risky procedure. It could, however, also represent the upward trajectory of SG over the last decade at the expense of Roux-en-Y Gastric Bypass (RYGB) in North America. It may also be because patients with fewer comorbidities were prioritized during this period and many surgeons reserve a gastric bypass for those with a higher metabolic burden of disease.

Unsurprisingly this study (1) found the postoperative outcomes of patients who underwent BS during the pandemic to be "similar" to the cohort before the pandemic. This is exactly what the global GENEVA study had found even though the GENEVA study did not have an in-built pre-pandemic cohort for a robust comparison. The GENEVA study had reported 30-day morbidity and mortality of 6.76% and 0.14% respectively in a global cohort of 7084 patients undergoing primary BS during the pandemic. The 30-day mortality of 0.13% reported in this study (1) bears striking resemblance to the figure of 0.14% observed in the GENEVA study.

Another interesting aspect of this study is a reduction in the length of stay of patients. This may be to ease the pressures on finite hospital resources and also to reduce the risk of acquiring SARS CoV-2 whilst in the hospital. In our unit, we were able to restart bariatric services sooner by adopting a one-night stay protocol for patients undergoing bariatric surgery.

In summary, we need to understand the effect of the pandemic on BMS for several reasons. Firstly, there is a real concern that the SARS-CoV-2 may never completely disappear. So, we need to re-examine the safety of all invasive procedures to be able to ameliorate their impact. Secondly, data on safety collected during the pandemic allow us to understand the efficacy of various preoperative strategies aimed at reducing perioperative SARS-CoV-2 infection. Finally, it allows us to estimate the activity lost as a result of the pandemic so we can plan to address it in the ensuing years.

J o u r n a l P r e -p r o o f

Impact of the COVID-19 pandemic on bariatric surgery in North America -A retrospective analysis of 834

COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Effect of COVID-19 pandemic on global Bariatric surgery PRActiceS-The COBRAS study

Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery

Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study

The impact of previous history of bariatric surgery on outcome of COVID-19. A nationwide medico-administrative French study